CADL and TRIN Related Headlines
Go Back- Candel Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
- Candel Therapeutics secures $130 million term loan facility with Trinity Capital
- Candel Therapeutics Enters into $130 Million Term Loan Facility with Trinity Capital Inc.
- Trinity Capital Inc. Provides $130 Million in Growth Capital to Candel Therapeutics, Supporting Development of Viral Immunotherapies to Fight Cancer
CADL and TRIN Related Press Releases
Go Back- Candel Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
- Candel Therapeutics Enters into $130 Million Term Loan Facility with Trinity Capital Inc.
- Trinity Capital Inc. Provides $130 Million in Growth Capital to Candel Therapeutics, Supporting Development of Viral Immunotherapies to Fight Cancer
